New drug cocktail shows promise for rare leukemia
NCT ID NCT05768711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of two drugs, azacitidine and venetoclax, in people with a high-risk form of chronic myelomonocytic leukemia (CMML). The goal is to see if the combo can shrink or control the cancer better than current treatments. About 44 adults will take part, and the study will also check for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Limoges
Limoges, 87046, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU d'Amiens
Amiens, 80054, France
-
CHU d'Angers
Angers, 49033, France
-
CHU de Bordeaux - Hôpital Haut-Lévêque
Pessac, 33604, France
-
CHU de Grenoble
Grenoble, 38043, France
-
CHU de Montpellier - Hôpital Saint Eloi
Montpellier, 34295, France
-
CHU de Poitiers
Poitiers, 86021, France
-
CHU de Tours - Hôpital Bretonneau
Tours, 37000, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Centre Hospitalier Annecy Genevois - Site d'Annecy
Pringy, 74374, France
-
Centre Hospitalier de Mont de Marsan
Mont-de-Marsan, 40000, France
-
Centre hospitalier Lyon sud
Pierre-Bénite, 69495, France
-
Hôpital Archet 1
Nice, 06200, France
-
Hôpital Avicenne
Bobigny, 93009, France
-
Hôpital Claude Huriez
Lille, 59037, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital NOVO
Pontoise, 95300, France
-
Hôpital Pontchaillou
Rennes, 35033, France
-
Hôpital Saint Louis
Paris, 75010, France
-
Hôpital privé Sévigné
Cesson-Sévigné, 35510, France
-
Hôpital privé du Confluent SAS
Nantes, 44277, France
-
IUCT oncopole
Toulouse, 31059, France
-
Institut Gustave Roussy
Villejuif, 94800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can a smart tool keep watch on leukemia after treatment stops?
- Can donor immune cells tame stem cell transplant risks?
- Can a Two-Drug combo tame a rare blood cancer?
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?